# Commission Delegated Regulation (EU) 2020/689 of 17 December 2019 supplementing Regulation (EU) 2016/429 of the European Parliament and of the Council as regards rules for surveillance, eradication programmes, and disease-free status for certain listed and emerging diseases (Text with EEA relevance), Article 85: Transitional provisions concerning existing eradication or surveillance programmes

Extent: E+W+S+N.I.

1. The Member States and zones thereof with an approved eradication programme or an approved surveillance programme before the date of application of this Regulation shall be deemed to have an approved eradication programme in accordance with this Regulation for the following diseases for a period of six years from the date of application of this Regulation:
(a) IBR/IPV, when the IBR/IPV eradication programme was approved in accordance with Directive 64/432/EEC;
(b) infection with ADV, when the Aujeszky’s disease eradication programme was approved in accordance with Directive 64/432/EEC;
(c) VHS, when the VHS surveillance or eradication programme was approved in accordance with Directive 2006/88/EC;
(d) IHN, when the IHN surveillance or eradication programme was approved in accordance with Directive 2006/88/EC;
(e) infection with HPR-deleted ISAV, when the infection with HPR-deleted ISAV surveillance or eradication programme was approved in accordance with Directive 2006/88/EC;
(f) infection with Bonamia ostreae, when the infection with Bonamia ostreae surveillance or eradication programme was approved in accordance with Directive 2006/88/EC;
(g) infection with Marteilia refringens, when the infection with Marteilia refringens surveillance or eradication programme was approved in accordance with Directive 2006/88/EC;
(h) infection with WSSV, when the white spot disease eradication programme was approved in accordance with Directive 2006/88/EC.
2. The compartments in Member States with an approved eradication programme or an approved surveillance programme before the date of application of this Regulation shall be deemed to have an approved eradication programme in accordance with this Regulation for the following diseases for a period of six years from the date of application of this Regulation:
(a) VHS, when the VHS surveillance or eradication programme was approved in accordance with Directive 2006/88/EC;
(b) IHN, when the IHN surveillance or eradication programme was approved in accordance with Directive 2006/88/EC;
(c) infection with HPR-deleted ISAV, when the infection with HPR-deleted ISAV surveillance or eradication programme was approved in accordance with Directive 2006/88/EC;
(d) infection with Bonamia ostreae, when the infection with Bonamia ostreae surveillance or eradication programme was approved in accordance with Directive 2006/88/EC;
(e) infection with Marteilia refringens, when the infection with Marteilia refringens surveillance or eradication programme was approved in accordance with Directive 2006/88/EC;
(f) infection with WSSV, when the white spot disease surveillance or eradication programme was approved in accordance with Directive 2006/88/EC.
3. The Member States deemed to have an approved eradication programme in accordance with paragraphs 1 or 2 shall ensure that the measures in the programme conform with those laid down for eradication programmes in this Regulation.

---
Source: https://www.legislation.gov.uk/eur/2020/689/article/85 (the official version)
Page: https://openlegislation.uk/eu-regulation-2020-689/article-85
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.